This control plane turns synthetic biotech change-control exports into one review surface: classification rationale, validation evidence, SOP acknowledgment freshness, approval continuity, audit-trail repair, and named cutover readiness before downstream release decisions.
| Lane | Owner | Status | Focus | Next action |
|---|---|---|---|---|
| Classification and scope lane The classification packet is not strong enough to defend the current change path. |
Quality Systems | red | Change class rationale, impact scope, and linked downstream dependencies | Close the unsigned rationale before another validation artifact inherits the wrong scope. |
| Validation and evidence lane Validation posture is currently the biggest release blocker. |
Validation Operations | red | Protocol execution, variance handling, and evidence completeness | Close the missing protocol evidence and signed variance note before the next board checkpoint. |
| Training and SOP lane Training posture is recoverable if the acknowledgments land in the next review cycle. |
Manufacturing Operations | yellow | Operator acknowledgment freshness and controlled cutover timing | Refresh the stale SOP acknowledgments before the packaging line enters the cutover window. |
| Approval and cutover lane The final board packet is not yet signoff-safe. |
Change Review Board | red | E-signature continuity, rollback readiness, and named release accountability | Close the missing approval signature and rollback handoff before opening the cutover window. |